RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
This Quarter Return
+10.05%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$630M
AUM Growth
+$630M
Cap. Flow
+$17.9M
Cap. Flow %
2.85%
Top 10 Hldgs %
30.71%
Holding
120
New
23
Increased
22
Reduced
38
Closed
13

Top Buys

1
SHPG
Shire pic
SHPG
$26.6M
2
MRK icon
Merck
MRK
$12.5M
3
TEVA icon
Teva Pharmaceuticals
TEVA
$12.4M
4
AGN
Allergan plc
AGN
$6.33M
5
UNH icon
UnitedHealth
UNH
$6.3M

Top Sells

1
GILD icon
Gilead Sciences
GILD
$20M
2
PFE icon
Pfizer
PFE
$13.2M
3
MDT icon
Medtronic
MDT
$11M
4
REGN icon
Regeneron Pharmaceuticals
REGN
$8.04M
5
CPHD
Cepheid Inc
CPHD
$8M

Sector Composition

1 Healthcare 86.01%
2 Financials 0.83%
3 Technology 0.09%
4 Energy 0.06%
5 Industrials 0.03%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NBIX icon
76
Neurocrine Biosciences
NBIX
$13.5B
$2.03M 0.32%
40,000
– –
ESPR icon
77
Esperion Therapeutics
ESPR
$490M
$1.8M 0.29%
130,000
-10,000
-7% -$139K
TNDM icon
78
Tandem Diabetes Care
TNDM
$834M
$1.79M 0.28%
23,400
+2,500
+12% +$192K
JNJ icon
79
Johnson & Johnson
JNJ
$429B
$1.77M 0.28%
+15,000
New +$1.77M
ICPT
80
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.65M 0.26%
+10,000
New +$1.65M
ACAD icon
81
Acadia Pharmaceuticals
ACAD
$4.34B
$1.59M 0.25%
50,000
– –
BHC icon
82
Bausch Health
BHC
$2.72B
$1.23M 0.2%
50,000
-160,000
-76% -$3.93M
TTPH
83
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.15M 0.18%
15,000
– –
RGLS
84
DELISTED
Regulus Therapeutics
RGLS
$990K 0.16%
2,500
-417
-14% -$165K
ANTH
85
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$945K 0.15%
37,500
– –
ADVM icon
86
Adverum Biotechnologies
ADVM
$68.2M
$633K 0.1%
15,401
– –
ATXS icon
87
Astria Therapeutics
ATXS
$372M
$616K 0.1%
1,667
-4,085
-71% -$1.51M
MD icon
88
Pediatrix Medical
MD
$1.45B
$596K 0.09%
9,000
-71,000
-89% -$4.7M
OREX
89
DELISTED
Orexigen Therapeutics, Inc.
OREX
$398K 0.06%
120,000
– –
MRTX
90
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$331K 0.05%
50,000
– –
CNCE
91
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$304K 0.05%
30,099
– –
OCUL icon
92
Ocular Therapeutix
OCUL
$2.25B
$275K 0.04%
40,000
– –
WFC icon
93
Wells Fargo
WFC
$258B
$200K 0.03%
+4,522
New +$200K
QCOM icon
94
Qualcomm
QCOM
$170B
$197K 0.03%
+2,869
New +$197K
CAT icon
95
Caterpillar
CAT
$194B
$193K 0.03%
+2,178
New +$193K
GKOS icon
96
Glaukos
GKOS
$5.42B
$192K 0.03%
5,100
– –
HAL icon
97
Halliburton
HAL
$18.4B
$190K 0.03%
+4,231
New +$190K
XOM icon
98
Exxon Mobil
XOM
$477B
$183K 0.03%
+2,102
New +$183K
IBM icon
99
IBM
IBM
$227B
$182K 0.03%
+1,196
New +$182K
MSFT icon
100
Microsoft
MSFT
$3.76T
$181K 0.03%
+3,140
New +$181K
1 2 3
4
5